Drugs / Curaleish
last change Jul 2022 re-read 3 minutes ago

Curaleish

Developed for
cutaneous leishmaniasis

Trials 0

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Comparator or background therapy1 trial
Phase 1/2 NCT04072874 Comparator Jan → Feb 2021 cutaneous leishmaniasis Universidad de Antioquia Withdrawn No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Curaleish ClinicalTrials.gov intervention name — accepted as the source's own label NCT04072874 ↗
Route Topical “will be applied topically by each participant” NCT04072874 ↗